Retinal Degeneration 3 (RD3) (N-Term) Peptide
RD3
Reactivité: Humain
Hôte: Synthetic
BP, WB
N° du produit ABIN982807
Aperçu rapide pour Retinal Degeneration 3 (RD3) (N-Term) Peptide (ABIN982807)
Antigène
RD3
(Retinal Degeneration 3 (RD3))
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- N-Term
-
Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-RD3 antibody (Catalog #: ARP55856_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- RD3 (Retinal Degeneration 3 (RD3))
-
Sujet
-
RD3 is preferentially expressed in retina.Defects in RD3 are the cause of Leber congenital amaurosis type 12 (LCA12).
Alias Symbols: C1orf36, LCA12
Protein Size: 195 -
Poids moléculaire
- 23 kDa
-
ID gène
- 343035
-
NCBI Accession
- NM_183059, NP_898882
-
UniProt
- Q7Z3Z2
Antigène
-
Vous êtes ici:
